The NEURO-TTRansform Study

is a Phase 3 clinical trial of an investigational antisense drug called eplontersen, formerly known as AKCEA-TTR-LRx, for people living with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN).

Study Icon

The Study arrow

Learn about how the NEURO-TTRansform trial works.

Location Icon

Find a Study Site arrow

Enter your location to see all study sites near you.

Location Icon

About hATTR-PN arrow

Read about hATTR-PN and current treatment options.